CIK 0001372514
- Non-accelerated filer
- Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980443284
- Phone
- +1 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-27 | GOLDBERG MORTON Director | Exercise or conversion | +1,083 | $1.70 | $2K | 18,360 |
| 2017-02-27 | GOLDBERG MORTON Director | Exercise or conversion · Stock Option (right to buy) | −1,083 | 1,917 | ||
| 2017-02-06 | Romano Sarah Interim CFO | Grant or award | +2,500 | 2,500 | ||
| 2017-02-06 | Mann Brenda VP of Research & Development | Grant or award | +2,500 | 11,751 | ||
| 2017-02-06 | MANZO MICHAEL P. Vice President of Engineering | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-02-06 | Wirostko Barbara Chief Medical Officer | Grant or award | +15,000 | 154,942 | ||
| 2017-02-06 | FROM STEPHEN President and CEO | Grant or award | +60,000 | 199,965 | ||
| 2016-09-15 | FROM STEPHEN President and CEO | Purchase | +15,000 | $1.49 | $22K | 139,965 |
Page 24 of 24 · 468 trades